All of our solutions can be performed via the following engagement types:
Short term contracts: you need a specialist parachuted in to resolve an urgent problem, or you know its only a short duration project
Interim contracts: there is a human resource shortage based on a maternity leave or peaks in your anticipated work load that are easier to fill with an external resource
Time restricted contracts: you need someone regularly but not full time
Long term contracts: you have a larger strategic plan in mind and want someone to take it in hand from A-Z
COMPANY PROFILE
Integrating late stage healthcare product launch, reimbursement and Health Technology Assessments with early stage innovation development in global markets to generate and facilitate implementable strategies that maximise value for all stakeholders
>45
Years
Experience
>600 mn
Funds
>150
HTA s
Managed
>10
Global ecosystems
designed & run
OUR MANAGEMENT TEAM
Combining Health Economics and Technology Assessments with Early Stage Innovation, Fund Raising, International Partnering and Ecosystem Design, Aestimo provides unparalleled expertise in cutting edge technology value maximisation
Maximillian Lebmeier
E-mail: MLebmeier@aestimo.ie
Phone: +44 7864 952 154
Maximilian (Max) is a health economist with over a decade experience in the pharmaceutical industry (Global, regional, UK / Ireland). He has worked on a wide range of disease areas from very common to very rare conditions including some of the worlds largest selling pharmaceutical products (Humira, Enbrel, Plavix, Yervoy, Abilify as well as many others). He has accumulated a broad depth of insights on identifying and generating value having worked on over 150 HTAs. Since 2016 he also runs Athena Market Access Solutions Ltd., providing pricing and market access solutions to organisations in the life sciences industry.
Dr. Jonathan Dando
E-mail: JDando@aestimo.ie
Phone: + 34 6 73 17 55 01
Jonathan (Jo) is an International Portfolio/Contract Manager with 22 years global experience, working with all stakeholders in early stage intervention design and development. He has managed over €600 million in R&D funding in global innovation healthcare projects, co-founded several hi tech start up’s and innovation consultancy firms. Since 2010 he also runs Echino Ltd, an innovation management company specialised in international partnering, development and ecosystem design. Ecosystem design has been performed for many global partnerships focusing on common and rare diseases as well as complex convergent technologies.